ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Advisory Council On The Misuse Of Drugs
Latest Government News
- Bluetongue virus – Latest situation: End of the seasonal low vector period
- Update on AUKUS export reform progress
- Bluetongue virus – Latest situation: End of the seasonal low vector period
- Guidance: Bluetongue: how to spot and report it
- Guidance: Apply for funding: space-related R&D, innovation and education
- Guidance: Closed opportunities: space-related R&D, innovation and education
- Enforcement appeals: Key changes under the Levelling Up and Regeneration Act
- Guidance: Feltham Prison and Young Offender Institution
- Guidance: United Kingdom Single Issuing Authority (UKSIA)
- National Statistics: Other PACE powers, year ending March 2023 (second edition)
Friday, 05 April 2024
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Thursday, 28 March 2024
A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).
Thursday, 28 March 2024
A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).
Wednesday, 27 March 2024
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
Wednesday, 27 March 2024
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
Thursday, 21 March 2024
Government response to the third addendum to the Advisory Council on the Misuse of Drugs' report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids.
Friday, 23 February 2024
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Friday, 16 February 2024
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Friday, 16 February 2024
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Wednesday, 14 February 2024
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Tuesday, 06 February 2024
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
Friday, 05 January 2024
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
Friday, 22 December 2023
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
Wednesday, 20 December 2023
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
Friday, 15 December 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Monday, 27 November 2023
Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
Monday, 27 November 2023
Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
Friday, 17 November 2023
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
Tuesday, 24 October 2023
Report from the Advisory Council on the Misuse of Drugs (ACMD) on consumer cannabidiol (CBD) products.
Monday, 23 October 2023
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Wednesday, 18 October 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Friday, 06 October 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Tuesday, 26 September 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
Thursday, 21 September 2023
The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.
Tuesday, 05 September 2023
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
Monday, 04 September 2023
The Home Secretary has today announced the reappointment of Professor Owen Bowden-Jones as the chair of the ACMD.
Wednesday, 30 August 2023
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Friday, 11 August 2023
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
Wednesday, 02 August 2023
The Home Office is looking for 16 new members to join the Advisory Council on the Misuse of Drugs (ACMD).
Thursday, 27 July 2023
Letter commissioning the Advisory Council on the Misuse of Drugs (ACMD) to work on a project to prevent drug use in children and young people.
Thursday, 27 July 2023
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Tuesday, 25 July 2023
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Tuesday, 25 July 2023
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Monday, 03 July 2023
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Friday, 30 June 2023
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Thursday, 22 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Tuesday, 20 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Friday, 16 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Thursday, 08 June 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
Friday, 26 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
Thursday, 25 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
Thursday, 25 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
Thursday, 11 May 2023
The government commissions the ACMD to conduct an updated harms assessment of synthetic cathinones.
Monday, 27 March 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments